Putnam Investments LLC Fate Therapeutics Inc Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Putnam Investments LLC holds 244,684 shares of FATE stock, worth $946,927. This represents 0.0% of its overall portfolio holdings.
Number of Shares
244,684
Previous 133,250
83.63%
Holding current value
$946,927
Previous $282,000
224.47%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding FATE
# of Institutions
190Shares Held
123MCall Options Held
15KPut Options Held
14K-
Redmile Group, LLC San Francisco, CA13.2MShares$51 Million2.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$40.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$39.1 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA8.22MShares$31.8 Million1.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.57MShares$21.6 Million0.6% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $375M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...